Versant Capital Management, Inc Gsk PLC Transaction History

Versant Capital Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$42.05 - $47.77 $1,261 - $1,433	30 New	30 $1,000
Q3 2021 Oct 29, 2021	SELL	$38.79 - $43.16 $10,667 - $11,868	-275 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$36.52 - $41.46 $10,043 - $11,401	275 New	275 $11,000
Q4 2020 Feb 08, 2021	SELL	$34.07 - $39.94 $10,527 - $12,341	-309 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$32.47 - $48.83 $10,033 - $15,088	309 New	309 $11,000
Q1 2018 Apr 19, 2018	SELL	$36.18 - $40.15 $6,186 - $6,865	-171 Closed	0 $0
Q4 2017 Apr 19, 2018	BUY	$35.34 - $41.9 $6,043 - $7,164	171	171 $6,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.